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Abstract
Background: Cancer is now viewed as a chronic disease, presenting challenges to follow-up and survivorship care.
Models to shift from haphazard, suboptimal and fragmented episodes of care to an integrated cancer care continuum
must be developed, tested and implemented. Numerous studies demonstrate improved care when follow-up is
assured by both oncology and primary care providers rather than either group alone. However, there is little
data on the roles assumed by specialized oncology teams and primary care providers and the extent to which they
work together. This study aims to develop, pilot test and measure outcomes of an innovative risk-based coordinated
cancer care model for patients transitioning from specialized oncology teams to primary care providers.
Methods/design: This multiple case study using a sequential mixed-methods design rests on a theory-driven realist
evaluation approach to understand how transitions might be improved. The cases are two health regions in Quebec,
Canada, defined by their geographic territory. Each case includes a Cancer Centre and three Family Medicine Groups
selected based on differences in their determining characteristics. Qualitative data will be collected from document
review (scientific journal, grey literature, local documentation), semi-directed interviews with key informants, and
observation of care coordination practices. Qualitative data will be supplemented with a survey to measure
the outcome of the coordinated model among providers (scope of practice, collaboration, relational coordination, leadership)
and patients diagnosed with breast, colorectal or prostate cancer (access to care, patient-centredness, communication,
self-care, survivorship profile, quality of life). Results from descriptive and regression analyses will be triangulated with
thematic analysis of qualitative data. Qualitative, quantitative, and mixed methods data will be interpreted within and
across cases in order to identify context-mechanism associations that explain outcomes.
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Discussion: The study will provide empirical data on a risk-based coordinated model of cancer care to guide actions at
different levels in the health system. This in-depth multiple case study using a realist approach considers both the need
for context-specific intervention research and the imperative to address research gaps regarding coordinated models
of cancer care.
Keywords: Case study, Coordination, Intervention, Mixed methods, Primary care, Risk-based cancer care, Realist evaluation
Background
The anticipated 79% increase in cancer survivors over the
next two decades, coupled with the scarcity of human and
financial resources [1] threatens to produce a crisis in
health systems across Canada and in most industrialised
countries [2, 3]. One way to potentially avert this crisis is
by implementing and evaluating integrated care models
that, while taking cancer-related risks into account, enable
more fluid transitions between specialized cancer care
teams and primary care providers (PCPs) [4–6]. Currently,
the siloed functioning of health systems hinders these
transitions [7, 8], leaving them incomplete, highly variable
and subject to informal agreements [9]. Badly coordinated
transitions are at root of unmet needs that have negative
consequences on health and quality of life [10]. As a re-
sult, survivors struggle with the human and economic
burden of living with cancer as a chronic disease [11, 12],
a burden it is now essential to alleviate.
The incidence of cancer and other chronic diseases
increases with age. An increasing number of adults and
seniors are living for many years with cancer alongside
other chronic diseases (e.g. diabetes, heart disease,
osteoporosis, depression). Care models must be better
adapted to the realities of a triple burden that combines
cancer survivorship, chronic disease [11, 13] and multi-
morbidity [10, 14]. All cancer survivors require follow-up
to manage the effects of cancer and its treatment, screen
for recurrence or the appearance of a new cancer, and co-
ordinate care [15]. About half of all cancer survivors
should, at minimum, undergo regular assessment of their
global state of health (information, symptom manage-
ment), while a third will require additional support (peer
support, health education). Between 35% and 40% of
survivors will need expert support to manage symp-
toms and distress, while 10% to 15% will require
close follow-up and more complex interventions [16].
This follow-up care must consider the physical, psy-
chological and side effect aspects of survivorship [16],
as well as multimorbidity [8, 17]. This is especially
important during transitions between specialized
cancer care and primary care with a family physician
[8, 9, 15]. Coordinated care models are therefore
sought by both clinicians and survivors to ensure that
needs are met in the right way, at the right time, by
the most appropriate professional [6].
The American Society of Clinical Oncology (ASCO),
the Canadian Cancer Research Alliance (CCRA), the
Canadian Partnership Against Cancer (CPAC) as well as
a vast literature review suggest that a model of inte-
grated care involving cancer care teams and primary
care providers (PCPs), and adapted to a person’s cancer-
related risk, could make the most of the expertise of
each group of professionals [4–6, 9, 18]. Such a model
requires communication through a survivorship care
plan between members of the cancer care team and
PCPs [19]. ASCO also highlighted the importance of
supporting “demonstration programs to test models of
coordinated, interdisciplinary survivorship care in di-
verse communities and across systems of care” (p.638)
[4]. Oncological risk (low, moderate or high) is based on
several factors, including the types of treatment re-
ceived, their toxicity, and the risk of recurrence [20];
an assessment of risk contributes to determining the
appropriate level of care, criteria for medical and psy-
chosocial referrals, and the resource(s) most able to
meet a person’s needs [20].
Despite these recommendations, the roles, responsibil-
ities and scope of practice of the various professionals par-
ticipating in survivorship care remain ill-defined [6, 10, 21].
Professionals in specialized teams do not always feel
equipped to respond to the totality of survivor needs, nor,
in overcrowded ambulatory clinics, do they always have
the time [10]. For their part, PCPs, notably family physi-
cians, consider they lack training in the follow-up of can-
cers, which involve more than 200 different diagnoses and
increasingly complex treatments [6, 22]. Furthermore,
Grunfeld’s work demonstrates that there is no added value
in having survivorship care provided by cancer specialists
rather than PCPs [23–27]. Given the haphazard, subopti-
mal and fragmented care currently available, and the rec-
ommendations from authorities in oncology, the present
project will produce robust evidence, applicable for rapid
use in different contexts, on a coordinated care model that
takes into account survivors’ cancer-related risk and poten-
tial multimorbidity.
Study aim and research questions
The goal is to develop, analyze and implement a demon-
stration project and evaluate the outcomes of a Risk-based
Coordinated Cancer Care Model (referred to hereafter by
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the acronym RbCCCM) that focuses on cancer survivors’
transitions between specialized oncology teams and pri-
mary care teams. This goal is formulated according to the
Medical Research Council’s stages of development for
complex interventions [28–30], and is specifically adapted
to people with chronic diseases [31]. The study will
address the following questions:
1. What are the contextual factors and mechanisms that
most effectively support a RbCCCM?
2. How, by whom, for whom and under what conditions
is the model translated into clinical and organizational
practice?
3. What are the model’s effects on professionals and
patients?
4. In what ways do context and mechanisms create
conditions that are favourable (or not) to producing
the outcomes of the RbCCCM?
Answering these questions involves mobilizing the
components of our theoretical framework and taking
a participatory approach, involving researchers/front-
line actors/patients, inspired by intervention research
[32–34]. Our working hypothesis is that a RbCCCM
involving specialized cancer care teams and primary
care teams will have a positive effect on professional
practice and, in the end, on the survivors’ experience
of transitions between teams.
The intervention
The RbCCCM is a novel intervention with multiple
components: professional, organizational, client-based
(patients and families), governance (Table 1). To address
the fragmentation of care, the RbCCCM relies on activities
that promote coordinated clinical and organizational
practices and on the behaviour of survivors during the
transition from oncology care to primary care [35, 36].
The RbCCCM incorporates consideration of cancer-
related risks that may combine with multimorbidity in
certain patients [31].
The intervention involves four interrelated steps: I) de-
velopment of a RbCCCM based on evidence around sur-
vivorship care models and an environmental scan of the
Québec context; II) implementation of a demonstration
project; III) measurement of the model’s effects on pro-
fessionals and survivors; and IV) evaluation of condi-
tions required for the RbCCCM to produce these effects.
Analytical framework of the RbCCCM
The analytical framework (Fig. 1) combines theoretical
work and empirical evidence from Tremblay et al.’s pre-
vious research [37, 38]. It is inspired by aspects of actor-
network theory (ANT), which, very briefly, holds that
translating a novel intervention into practice depends on
the ability of multiple actors — with diverse interests,
needs and objectives that are often in competition — to
work together towards a common goal [39–41]. The
construction of this network to support an intervention
(the RbCCCM in our case) proceeds in four key stages
along the path from idea to practice: contextualization
(identification of actors/resources and the play of influ-
ence at different levels); problem definition (discussion/
decision-making processes to clarify the problem and its
solution, determine mechanisms that need to be acti-
vated and the initial intervention theory); mobilization,
whereby actors become interested in the innovation
(interessement), assume roles (enrolment) and commit
(commitment) to achieving the anticipated outcomes of
the innovation and monitoring processes and effects
[42]. To render the ANT more concrete in operational
Table 1 Components of the RbCCCMa
Components Planned activities Deliverables
Professional • Identification of needs (e.g..: continuing education, clinical
toolsb, skills development)
• Oncological risk evaluation and multimorbidity (health status)
• Clarification of roles
• Online training modules
• Criteria for referrals between teams
• Identify and develop clinical tools (survivorship care plan)
Organizational • Development/adaptation of coordination and
communication tools
• Consolidation of intra- and inter-team work
• Identify organizational actions for teamwork
• Design effective service corridors
Clientelec • Development/adaptation of information tools
• Identification of community resources
• Development/adaptation of education for clientele
(self-care, symptom management, navigation in
health system)
• Paper and web publications
• Survivorship workshop
• Adapted monitoring tools
• Inventory of resource persons
Governance (policy makers,
administrators)
• Establishment of normative and legislative aspects related
to survival issues
• Establishment/consolidation of a provincial survivorship
committee (mandates and responsibilities)
• Recommendations/incentives
• Recognition/clinical time for survivorship care
• Mention of RbCCCM in provincial and national cancer
and action plans
aTo be validated in Step I: development of the intervention with the decision–making partners
bOngoing procedures for translating clinical reference tools from the Oncology Nursing Society
cClientele refers to cancer patients and their families
Tremblay et al. BMC Health Services Research  (2017) 17:834 Page 3 of 12
terms, the framework includes principles of realist evalu-
ation [43–46]. Realist evaluation is an approach that
brings together: 1) the multi-level context and its
influence on professional and organizational practice as
well as the experience of people living with cancer
(contextualization (C)) [47]; 2) development of a com-
mon definition of the problem and identification of the
novel intervention’s components, leading to the develop-
ment of an initial theory of RbCCCM (problem defin-
ition); 3) activation of mechanisms (M) in terms of
people’s interessement, enrolment and commitment to
the RbCCCM (mobilisation); and 4) monitoring of antic-
ipated or unanticipated outcomes (O) in professional
and organizational practice and the experience of cancer
survivors (monitoring). The successful translation of the
intervention (RbCCCM) into practice would involve the
achievement of positive effects without producing un-
anticipated negative effects. The arrows in the figure
illustrate that the translation process is not necessarily
linear. For more details see Additional file 1.
Methods/design
The methodological approach (Fig. 2) is adapted to our
research questions and to the stages involved in develop-
ment, implementation, and evaluation of the interven-
tion [48], along with conditions required to produce the
outcomes of the RbCCCM. Methods have also been
strategically chosen for pragmatic qualities suited to
interventional research (Table 2). The design involves a
multiple case study based on qualitative data that draws
on the principles of realist evaluation and quantitative
data in an experimental approach.
The RbCCCM intervention
Step I - Development
Development of the RbCCCM begins by gathering
evidence [30, 48] on integrated survivorship models
(components, activities, professionals involved, nature
and scale of effects, theoretical bases) [49] and the concept
of cancer-related risk. This will be followed by an environ-
mental scan of existing local initiatives in Québec to pro-
mote coordination between cancer care and primary care.
This step will provide answers to Question 1.
A scoping review will be undertaken in six stages
[50, 51]: 1) identify the research question; 2) identify
relevant studies; 3) select studies according to inclu-
sion and exclusion criteria; 4) classify evidence by
theme and challenge area; 5) assemble, summarize
and report results; and 6) consult potential users to
determine where we are with transitions (contextual-
isation), where we want to be (problem definition)
and what is needed to get there (mobilization) and
what outcomes are anticipated (monitoring).
These steps are in line with the analytical framework
presented in Fig. 1. We will use the Nose to Tail Tool
(NTT) internet platform [52], which enables delibera-
tive processes (participatory group work) around the
development and planning of innovative interventions,
the context in which they will be used, and the decision
to move ahead with implementation. This will involve
Fig. 1 Framework developed for the analysis of the RbCCCM intervention
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key informants from the primary care and nursing
committee of the Direction générale de cancérologie du
Québec, managers and clinicians from cancer care
teams, and Family Medicine Groups (FMGs).
The deliverable is the concerted production of the
RbCCCM logic model [53] that will specify contextual fac-
tors and challenges, training needs of professionals, and re-
sources available (or possible to recruit) to implement the
RbCCCM. Finally, depending on results, accredited online
training modules (cancer and treatments, interdisciplinary
care, survivorship, assessment of cancer-related risk,
multimorbidity, health promotion, professional and patient
resources) will be developed or adapted. An expert recog-
nized for clinical leadership will be recruited to adapt or de-
velop training to support clinical judgement in survivorship
interventions and provide coaching. The training will be
offered in collaboration with the leader of the nursing com-
mittee at the Direction générale de cancérologie.
Demonstration project
The design for analyzing the implementation (Step II)
and evaluation of outcomes (Step III) is a multiple case
Fig. 2 Graphic illustration of the methodological approach. Legend: Q1-Q4: Research questions; QUAL and QUAN refer respectively to qualitative
and quantitative data; a Refers to the definitions of Miles MB, Huberman M, Saldana J. Qualitative data analysis. A Methods Sourcebook. 3 ed.
Thousand Oaks: Sage, 2014, p. 278-279; b Refers to the definitions of Creswell JW. Research Design: Qualitative, Quantitative, and Mixed
Methods Approaches. 3 ed. Thousand Oaks: SAGE Publications; 2009, p.162; C: Context, M: Mechanisms, O: Outcomes
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study [54] based on qualitative and quantitative data
[55]. The design is appropriate to understanding a con-
temporary phenomenon (the RbCCCM) as it manifests
in the real world where it may be influenced by multiple
changing and interdependent factors and contextual
challenges. A case is defined as the cancer care trajectory
in order to understand how the RbCCCM mobilizes
members of specialized cancer care teams and primary
care teams during transitions.
The selection of cases is based on theory [54] to repre-
sent real-world differences [56] in terms of geographic
location (the territorial expanse served; rural/semi-
urban/urban areas), mission (academic or not), the size
and diversity of care teams and their interest in being in-
volved in the RbCCCM demonstration project. Units of
analysis are the hospital-based cancer care teams and
the FMGs of two Integrated Health and Social Service
Centres (3/11 FMGs + one hospital in Saguenay-Lac-
Saint-Jean (Case 1); 3/31 FMGs + one hospital in the
Montérégie (Case 2). The selection of cases is also influ-
enced by feasibility and our knowledge of these estab-
lishments gained through their participation in prior
research we conducted on cancer care [8, 37, 38, 57–63],
on primary care [64, 65], as well as on organizational
factors that influence the care experience of people hav-
ing received a cancer diagnosis [38].
Case 1 is an academic health centre that has deployed,
since 2010, an intervention in FMGs aimed at improving
care coordination for people with chronic diseases (other
than cancer) through nurse case managers and group ses-
sions to support self-management [64, 65]. In this case,
the RbCCCM might be integrated into these existing prac-
tices, with cancer treated as a chronic disease [13]. Case 2
has, since 2001, deployed efforts in specialized cancer care
(nurse navigators, implementation of a cancer care net-
work, development of an integrated centre, introduction
of the clinician advisor role) [37, 38, 60, 63, 66, 67]. The
two cases offer possibilities for analyzing the RbCCCM
and better understanding variations in implementation
and outcomes. The realist approach is employed for its
pragmatic and participatory principles that help to dis-
cover what works (and what doesn’t), how it works, for
whom, and under what conditions. This approach is
suited to analysis of complex interventions [48].
Table 2 Elements involved in steps I to IV and data collection
Professionals
Elements Policy makers,
administrators
PCP Onco. Patients, families Documents
Step I - Development
• Scientific evidence: scoping study PWG PWG PWG PWG SDB
• Environmental scan: identification of actors, issues, needs PWG PWG PWG PWG
• Development of the initial theory of the intervention PWG PWG PWG PWG
• Production of the logic model of the intervention PWG PWG PWG PWG
Step II - Implementation
• Adoption/adaptation into practice II II, O II, O TC LR
• Description of ongoing incentives, mobilization, commitment II II II TC LR
• Identification/description of mechanisms for translation into practice II II, O II, O TC LR
• Identification/description of facilitating and constraining
factors/reduction of barriers
II II, O II, O TC LR
Step III – Outcomes
For professionals
• Scope of practice; teamwork; work environment S S
• Shared leadership; density/centrality of the cancer network S S
• Socio-demographic characteristics S S
For patients
• Responsiveness; self-care capacity; quality of life; out-of-pocket costs S, PD
• Socio-demographic and clinical characteristics S
Step IV- Configuration
Global evaluation
• Context-Mechanisms-Outcomes (C +M = O) IVI IVI IVI IVI
Legend: LR Literature review, II Individual interview, IVI Individual validation interview, PWG Participative working group, O Non-participant observation, S Survey,
TC Tracer cases, SDB Scientific data bank, PD Patient diary
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Step II – Implementation (pilot test)
Analysis of the implementation of the RbCCCM [30]
will enable us to explain how and why the program is
translated into clinical and organizational practices, with
whom, for whom, and under what conditions. It will
focus on the four moments of translation of the ANT to
see how actors relate to the RbCCCM. In concrete
terms, the analysis will reveal the “pros” and “cons” with
regard to the RbCCCM and how these controversies are
resolved to recognize the RbCCCM as a necessary
bridge towards coordinating survivorship care during
transitions. This step will explain how cooperative
mechanisms are activated by the development of mu-
tual trust and sharing of expertise, leadership, and the
use of coordination and communication tools (e.g.
professional time, referral criteria, clinical practice
guidelines, problem detection tools) in a given con-
text. This step will complete the response to Question
1 and will answer Question 2.
Sampling (step II)
Participants are people living with cancer, and members
of the cancer care teams and FMGs involved in treating
these patients.
The patient sample will be made up by survivors who
have been diagnosed with cancer and have completed
active treatment. Inclusion criteria are: to have been di-
agnosed with cancer (breast, colorectal, prostate), to
have completed active treatment, to have received over
the past 12 months or currently be receiving care other
than palliative care in one of the outpatient cancer
clinics involved in the study (Montérégie or Saguenay-
Lac-Saint-Jean), to have a family physician belonging to
one of the participating FMGs, and to be able to read
and speak French. The types of cancer have been se-
lected based on age-related incidence and 5-year survival
rates (88% for breast, 64% for colorectal, and 96% for
prostate) [1].
The professional sample will be made up by members
of cancer care and FMG teams (family physicians, spe-
cialist physicians, nurses, other professionals and man-
agers). Inclusion criteria are: to be a family physician
working in a FMG where the client base includes people
living with cancer, a specialist physician affiliated with
the oncology department of a participating site, a nurse
(nurse navigator, clinical nurse specialist or nurse practi-
tioner in a FMG) or another professional working with
people living with cancer.
Procedure (step II)
Project collaborators and partners are committed to
facilitating the recruitment of professionals and patients.
For patients, a locally-designated person will identify po-
tential participants and provide them information about
the study. Interested patients will be invited to sign an
“Authorization to be contacted” and a member of the re-
search team will provide them the information required
for informed consent. For professionals, an email mes-
sage inviting them to participate will be sent out via in-
ternal email lists, and will include a link to a brief video
(3 min) presenting the study (objectives, duration of the
interview, type of questions asked). A positive response
to the email will be followed by setting an appointment
for the interview at the participant’s convenience.
Compensation to a maximum of $100 is anticipated for
the time involved in the interview (professionals and pa-
tients). The amount will be adjusted to the duration of
the interview when participants indicate availability of
less than one hour.
Qualitative data collection (step II)
Qualitative data will be collected from a number of
sources: semi-directed interviews with key informants (pa-
tients, professionals, managers) (n = 12 per case) [68],
document analysis (tools used in care coordination and
continuity, chart review, meeting minutes) [69] and obser-
vation (follow-up appointments, team meetings). Tracer
patients, referring to patients followed throughout the
healthcare process [70, 71], will enable documentation of
transitions in real time (interviews, observation, clinical
chart). The selection of tracer patients (n = 16) will be
based on cancer type (breast, colorectal, prostate) and af-
filiation with a family physician in a FMG involved in one
the two cases of the study. Patients over 70 years of age
will make up 50% of tracer cases given their increased po-
tential for multimorbidity [72], the recognition of unmet
needs in this group [73] and the challenges of an inte-
grated oncogeriatric approach [67]. Professionals involved
in the care of these tracer patients will be interviewed to
incorporate views on the context and mechanisms (active
ingredients) of real-world care transitions from people
directly involved in the RbCCCM.
Qualitative data analysis (step II)
Systematic and iterative content analysis will involve lis-
tening to the audio of interviews, reading and coding all
data [54] integrated into a QDA Miner database. A
semi-open analytical grid, based on the analytical frame-
work (Fig. 1) will enable an initial coding structure and
the addition of new codes during analysis [74]. Each case
will be analyzed separately, followed by an inter-case
analysis to highlight recurring models, differences and
similarities between the cases (semi-regularities) [43].
Validity (step II)
Validity is increased through the triangulation of mul-
tiple data sources [54] and the interactions between re-
searchers and potential knowledge users. Collaborative
Tremblay et al. BMC Health Services Research  (2017) 17:834 Page 7 of 12
coding based on solid theory and concepts, along with
validation of findings by users will contribute to internal
validity (credibility). The detailed description of the
RbCCCM and cases will contribute to external validity
(transferability) and the pragmatic aims of the study.
Step III - Outcomes of the RbCCCM
This stage aims to understand the outcomes of the
RbCCCM in patients and professionals in each of our
cases. It uses experimental approaches to verify our
working hypothesis that the RbCCCM will have a
positive impact on professional practice and the care ex-
perience of cancer survivors (patient-reported experi-
ence). The impossibility, for ethical and professional
reasons, of conducting a randomized controlled trial
calls for a pragmatic before-and-after design with de-
layed intervention (6-month follow-up) where teams in
one case will provide usual care (control segment) while
teams in the other case are implementing the compo-
nents of the intervention (intervention segment). This
step will answer Question 3.
Sample (step III)
The sample size is calculated according to our previous
studies on the responsiveness of cancer care [75] and
the Health Education Impact Questionnaire (heiQ) scor-
ing for self-management capacity [76]. Given that scores
on the scales range between 1 and 4, an average score of
2.3 and a difference of 0.3 are reasonable. One hundred
patients per case will be recruited, based on anticipated
attrition of about 10%. If we consider the heiQ distress
score, this sample size would enable us to detect a 0.3
difference between measures at 2 time points in a same
group, and between groups, with a standard deviation of
0.71 and confidence interval of 0.80.
The sample size will include about 50 professionals
per case (100 total) including personnel in the FMGs
and the cancer care teams. The minimum response rate
based on our previous studies is anticipated at 40%.
Limitations related to the small sample size will, as is
common in case studies, be compensated by the qualita-
tive data described in Step II [77].
Procedure (step III)
The patient recruitment process is based on our previ-
ous studies. It relies on collaboration from care teams to
help us identify potential patient participants. Standar-
dised criteria and recruitment procedures will be used
and a local professional (the research nurse in our study)
will be designated to explain the study and obtain in-
formed consent. If the patient agrees to participate, they
will be given a postage-paid envelope, information letter
and printed questionnaire. Patients may also choose to
complete the questionnaire on line (SurveyMonkey Inc.,
San Mateo, California, USA). In this case, patient
participants will be given an access code. Questionnaires
are anonymous and managed to respect confidentiality.
Reminders and a compensation of $25 aim to increase
response rates.
All professionals working in specialized cancer care
and primary care teams will receive an invitation by
email that includes a link to a short video explaining the
study objectives and expectations of participants. The
questionnaire will be provided in print and on line
(SurveyMonkey Inc., San Mateo, California, USA).
Three reminders at two-week intervals, along with
marketing through communities of practice, scientific
networks (e.g. RRISIQ, Réseau 1, CANO) and social
media, along with compensation of $25, aim to in-
crease response rates [78].
Quantitative data collection (step III)
Anticipated outcomes in patients will be measured be-
fore the intervention (T0) and six months after the start
of the RbCCCM (T1). A self-administered questionnaire
(30 min) will measure the patient’s perception of their
experience of care during transitions between teams:
responsiveness [75]: timeliness of access (4 items; α =
0.77), person-centred care (5 items, α = 0.67), quality of
communication (5 items, α = 0.85), self-management
capacity based on the heiQ validated in oncology [76],
involving: emotional distress (6 items; α = 0.77), wayfind-
ing in the health system (5 items, α = 0.85), social sup-
port and integration (5 items, α = 0.85), as well as quality
of life SF12 (12 items, α = 0.83) [79]. Though the project
does not include an economic evaluation, data related to
some costs will be collected, notably among men with
prostate cancer [80], using a generic instrument and a
diary to report costs of using health care (time, trans-
port costs, non-reimbursed medication costs, lost in-
come). This data will provide the basis for economic
analysis in a future study. Sociodemographic and
clinical data will be collected: age, gender, comorbid-
ity, cancer type, health status, chronic diseases [81],
survivorship profile [82].
Anticipated outcomes among professionals will be mea-
sures before the intervention (T0) and 6 months after the
start of the RbCCCM (T1), an interval based on feasibility
in a demonstration project. A self-administered question-
naire (30 min) with validated psychometric properties will
be employed: SCOP scope of practice (26 items, α = 0.89)
[83], teamwork (5 items, α = 0.84) [84], team environment
(19 items, α = 0.88–0.93) [85], shared leadership (13 items,
α = 0.66) [86]. The density and centrality of intra- and
inter-team links will be measures using social network
analysis [87]. Data on sociodemographic characteristics
will also be collected (age, gender, profession, practice set-
ting, years of experience).
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Quantitative data analysis (step III)
Descriptive statistical analyses, comparative analyses
based on data type (t-test, Chi2, ANOVA, ANCOVA),
and regression analyses (multilevel logistic and linear
because of the structure and hierarchy of data) will be
conducted. These will enable us to determine the
association (positive, negative or neutral) between the
RbCCCM, professional practice, and the care experience
of cancer survivors during transitions, while controlling
for certain potentially confounding individual and
organizational variables. The threshold for significance
will be 5%.
Validity (step III)
Internal validity rests on use of questionnaires with
validated psychometric strengths, sample size, and con-
trol of confounding variables in the regression models.
Results will be generalizable to other settings with char-
acteristics similar to the cases in the study.
Step IV – Analysis of conditions required for the production
of outcomes
The outcomes of the RbCCCM depend on a number of
contextual, human and clinical factors that may act
synergistically or antagonistically. A configurational ap-
proach is suited to the analysis of conditions that under-
lie production of the outcomes in complex interventions
[88] in order to understand critical factors in the
RbCCCM that contribute to developing lasting fluidity
in the transitions between care teams. Realist evaluation
provides the methodological basis, stipulating that the
association between context (C) and mechanisms (M)
produces the outcomes of an intervention (O): C +M=O
[43]. These configurations represent semi-regularities:
“regularities” because they are recursive models with
strong explanatory potential; “semi” because these recur-
sive models are highly dependent on context and can vary.
This step will answer Question 4.
Results from qualitative analysis (C +M drawn from
Steps I and II) and quantitative analysis (outcomes
measured in Step III) will be combined [89] in order to
develop the C +M =O associations of the RbCCCM
[43, 88]. All data will be integrated into a database in
QDA Miner (Provalis Research) to produce configura-
tions that offer a clear, rich and detailed understand-
ing of the RbCCCM as an innovative intervention,
providing a refined theory of the intervention. Results
will be validated pragmatically among researchers,
front-line actors and patient participants. The validity
of data integration rests on quality criteria from the
Mixed Method Appraisal Tool available on WIKI [90]
and on perceptions of actors in the field.
Knowledge transfer plan
In line with the Knowledge to Practice framework [91],
our knowledge exchange strategy considers the particu-
lar needs of each knowledge user. The research ap-
proach therefore involves key informants and users in
the development of the RbCCCM intervention. This
strategy enables the targeting of significant evidence to
potential users and the adaptation of the intervention to
local contexts (clinical tools, referral criteria). As well,
the inclusion of knowledge users and partnership with a
cancer survivor on the research team enable the identifica-
tion of facilitators and impediments (e.g. lack of know-
ledge about survivorship care) to the implementation of
the RbCCCM. Effective strategies to overcome these ob-
stacles may then be used as educational interventions
(accredited continuing medical education) or as interven-
tions led by patients (e.g. patient awareness of the
RbCCCM leads them to request a survivorship plan from
their specialist). To promote and deepen exchanges,
knowledge users will be informed on a regular basis about
progress on the project (e.g. newsletter, agenda item on
monthly clinical meetings). As well, the research team will
organise (1×/year) a half-day knowledge exchange sympo-
sium on themes related to the RbCCCM (presentation of
scoping review, preliminary results).
Components of the Knowledge to Practice framework
are the cornerstone of our integrated knowledge transfer
(IKT) plan [91] and are suitable for the study of innova-
tive interventions. This framework defines knowledge
uptake as a dynamic and recursive process that involves
the synthesis, dissemination, exchange and uptake of
knowledge with a view to improving care and strength-
ening the health system. This process takes place within
a network of complex interactions between researchers
and knowledge users that vary in intensity, complexity
and commitment depending on the nature of the re-
search and its results, as well as the particular needs of
each knowledge user. It is therefore consistent with
interventional research. The framework has two central
components. The first draws on the notion of the funnel,
where the creation of knowledge involves its progressive
refinement to facilitate adoption by actors in the field.
The second represents the active part of the process as a
cycle leading to the implementation or application of
research findings. This second component involves seven
stages that may be sequential or occur in feedback loops:
1) problem identification, 2) adaptation of knowledge to
local context, 3) assessment of barriers to knowledge use
in that context, 4) selection, adaptation and implementa-
tion of interventions, 5) monitoring of knowledge use, 6)
evaluation of results, and 7) maintenance of knowledge
use. The framework is perfectly aligned with the analytical
framework developed in this project (Fig. 1) and will guide
us towards the interventional research goals.
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Discussion
Challenges and mitigation strategies
Potential difficulties in this project are: 1) the engage-
ment of professionals and their willingness to collabor-
ate; 2) recruitment of patients; 3) the distance separating
the two cases; 4) the large scope of the project. The fol-
lowing strategies will be adopted to reduce attendant
risks: first, we have secured the participation of research
nurses, remunerated by the project and recognized in
each of the case settings for their clinical leadership and
coaching abilities [92]. They will be able to quickly identify
problems that arise with the implementation of the
RbCCCM, work with the research team to find solutions
suitable to the local context, and counsel team members
on complex cases. Second, institutional leadership
support for the project creates winning conditions.
Québec institutions must periodically design and
evaluate their cancer action plans, and care and ser-
vice continuity is a priority in these plans. Finally, the
presence of the RbCCCM will be seen by teams as a
useful and supportive project.
The study will enable us to develop a Risk-based
coordinated cancer care model (RbCCCM), to analyze
the implementation of a demonstration project, and
to evaluate the outcomes of the RbCCCM. It will
allow us to test the RbCCCM in various practice
communities across the health system. Anticipated re-
sults will: 1) identify factors that facilitate or impede
a RbCCCM, 2) evaluate how the model is translated
into clinical and organizational practice, 3) evaluate out-
comes in professionals and patients, and 4) identify
contexts and mechanisms that create favourable and un-
favourable conditions for the production of RbCCCM
outcomes. This will provide essential information for
decision-makers and managers about the roles and re-
sponsibilities assumed by cancer and primary care teams
in the provision of care and at transition points along the
cancer care continuum. In addition, the project will in-
crease awareness among a broad range of stakeholders
(policy-makers, managers, professionals, services users) of
factors that help to activate promising mechanisms
involved in a coordinated model of cancer care.
Additional file
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